ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CYBG Ve Bionic Etf

17.27
0.219 (1.28%)
23 Apr 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Ve Bionic Etf LSE:CYBG London Exchange Traded Fund
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.219 1.28% 17.27 17.158 17.348 17.356 17.236 17.356 1 16:35:00

Virgin Money UK PLC Publication of Final Terms (5310Y)

09/09/2020 4:55pm

UK Regulatory


Ve Bionic Etf (LSE:CYBG)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Ve Bionic Etf Charts.

TIDMVMUK TIDM91XR

RNS Number : 5310Y

Virgin Money UK PLC

09 September 2020

VIRGIN MONEY UK PLC

(Company)

LEI: 213800ZK9VGCYYR6O495

9 September 2020

Publication of Final Terms

The following final terms (the "Final Terms") are available for viewing:

Final Terms dated 9 September 2020 relating to the Series 6 GBP475,000,000 5.125 per cent. Fixed Rate Reset Callable Subordinated Tier 2 Capital Notes due 2030 issued by the Company under the GBP10,000,000,000 Global Medium Term Note Programme of the Company and Clydesdale Bank PLC

Please read the disclaimer below "Disclaimer - Intended Addressees" before attempting to access this service, as your right to do so is conditional upon complying with the requirements set out below.

To view the full document, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/5310Y_1-2020-9-9.pdf

A copy of the above document has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

Announcement authorised for release by Lorna McMillan, Group Company Secretary.

Enquiries

 
 Investors and Analysts 
 Andrew Downey                 +44 203 216 2694 
                              ------------------------------------ 
 Head of Investor Relations    +44 7823 443150 
                              ------------------------------------ 
                               andrew.downey@virginmoneyukplc.com 
                              ------------------------------------ 
 
 Company Secretary 
                              ------------------------------------ 
 Lorna McMillan                + 44 7834 585436 
                              ------------------------------------ 
 Group Company Secretary       lorna.mcmillan@virginmoneyukplc.com 
                              ------------------------------------ 
 
 Media Relations 
                              ------------------------------------ 
 Press Office                  0800 066 5998 
                              ------------------------------------ 
                               press.office@virginmoneyukplc.com 
                              ------------------------------------ 
 

DISCLAIMER - INTENDED ADDRESSEES

IMPORTANT: You must read the following before continuing: The following applies to the Final Terms available by clicking on the link above, and you are therefore advised to read this carefully before reading, accessing or making any other use of the Final Terms. In accessing the Final Terms, you agree to be bound by the following terms and conditions, including any modifications to them, any time you receive any information from us as a result of such access.

The Final Terms must be read in conjunction with the base prospectus dated 5 February 2020 relating to the GBP10,000,000,000 Global Medium Term Note Programme of the Company and Clydesdale Bank PLC, as supplemented by the supplemental prospectuses dated 13 May 2020 and 28 August 2020 (the "Base Prospectus"), which comprises a prospectus for the purposes of the Prospectus Regulation (Regulation (EU) 2017/1129).

THE FINAL TERMS MAY NOT BE FORWARDED OR DISTRIBUTED OTHER THAN AS PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY MANNER WHATSOEVER. THE FINAL TERMS MAY ONLY BE DISTRIBUTED OUTSIDE THE UNITED STATES TO PERSONS THAT ARE NOT U.S. PERSONS AS DEFINED IN, AND IN RELIANCE ON, REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"). ANY FORWARDING, DISTRIBUTION OR REPRODUCTION OF THE FINAL TERMS IN WHOLE OR IN PART IS PROHIBITED. FAILURE TO COMPLY WITH THIS NOTICE MAY RESULT IN A VIOLATION OF THE SECURITIES ACT OR THE APPLICABLE LAWS OF OTHER JURISDICTIONS.

NOTHING IN THIS ELECTRONIC PUBLICATION CONSTITUTES AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DO SO.

Please note that the information contained in the Final Terms and the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and the Base Prospectus is not addressed. Prior to relying on the information contained in the Final Terms and the Base Prospectus you must ascertain from the Final Terms and the Base Prospectus (as applicable) whether or not you are part of the intended addressees of the information contained therein.

Confirmation of your Representation: In order to be eligible to view the Final Terms or make an investment decision with respect to these Notes, you must be a person other than a U.S. person (within the meaning of Regulation S under the Securities Act). By accessing the Final Terms you shall be deemed to have represented that you and any customers you represent are not a U.S. person (as defined in Regulation S to the Securities Act) and that you consent to delivery of the Final Terms via electronic publication.

You are reminded that the Final Terms have been made available to you on the basis that you are a person into whose possession the Final Terms may be lawfully delivered in accordance with the laws of the jurisdiction in which you are located and you may not, nor are you authorised to, deliver the Final Terms to any other person.

The Final Terms and the Base Prospectus do not constitute, and may not be used in connection with, an offer or solicitation in any place where offers or solicitations are not permitted by law. If a jurisdiction requires that the offering be made by a licensed broker or dealer and the underwriters or any affiliate of the underwriters is a licensed broker or dealer in that jurisdiction, the offering shall be deemed to be made by the underwriters or such affiliate on behalf of the Company in such jurisdiction. Under no circumstances shall the Final Terms or the Base Prospectus constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of any Notes issued or to be issued pursuant to the Final Terms or the Base Prospectus, in any jurisdiction in which such offer, solicitation or sale would be unlawful.

The Final Terms have been made available to you in an electronic form. You are reminded that documents transmitted via this medium may be altered or changed during the process of electronic transmission and consequently none of the Company, its advisers or any person who controls the Company or any director, officer, employee or agent of the Company or affiliate of any such person accepts any liability or responsibility whatsoever in respect of any difference between the Final Terms made available to you in electronic format and the hard copy version available to you on request from the Company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PFTEKLFBBKLEBBL

(END) Dow Jones Newswires

September 09, 2020 11:55 ET (15:55 GMT)

1 Year Ve Bionic Etf Chart

1 Year Ve Bionic Etf Chart

1 Month Ve Bionic Etf Chart

1 Month Ve Bionic Etf Chart

Your Recent History

Delayed Upgrade Clock